Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease

NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

NCT02531113 ·Status: COMPLETED ·Phase: PHASE2

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

NCT00130390 ·Status: TERMINATED ·Phase: PHASE2

AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease

NCT05452304 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

NCT00321412 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease

NCT02249078 ·Status: WITHDRAWN ·Phase: PHASE1

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

NCT02247258 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT03650413 ·Status: TERMINATED ·Phase: PHASE2

A Study of Abatacept in Patients With Active Crohn's Disease

NCT00406653 ·Status: TERMINATED ·Phase: PHASE3

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

NCT05599347 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

NCT01235689 ·Status: COMPLETED ·Phase: PHASE3

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

NCT02579733 ·Status: TERMINATED ·Phase: PHASE4

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

NCT04173273 ·Status: TERMINATED ·Phase: PHASE3

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

NCT00297193 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02378688 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

NCT02367183 ·Status: COMPLETED ·Phase: PHASE1

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

NCT01751152 ·Status: COMPLETED ·Phase: PHASE2

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Control Crohn Safe Trial

NCT03917303 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

NCT02048618 ·Status: COMPLETED ·Phase: PHASE2

Reduce Risk for Crohn's Disease Patients

NCT02852694 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2